Merani has been the lead intellectual property counsel on deals worth more than $2 billion in the last two years, including two recent deals worth $104 million and $64 million, for cutting-edge cancer immunotherapy and gene editing technologies. She was also lead counsel for a medtech company that was recently acquired for $600 million.
What’s your biggest pet peeve related to working in the tech sector?
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
